Endometrial Cancer Trial, Recruiting NCT07318415 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07318415
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a primary cancer of the uterine lining (endometrial carcinoma), including specific types such as endometrioid, serous, clear cell, dedifferentiated/undifferentiated, mixed epithelial, adenocarcinoma not otherwise specified, and carcinosarcoma
  • People whose initial surgery included removal of the uterus (hysterectomy), both ovaries and fallopian tubes, and an assessment of the pelvic lymph nodes (either by a mapping/sampling method or full removal)
  • People whose surgery successfully removed all visible cancer, with no cancer found at the edges of the removed tissue and no remaining disease after the operation
  • People whose cancer was confirmed as stage I or II (early stage) based on what was found during surgery, using the 2009 FIGO staging system
  • People aged 18 years or older
  • People who are able to begin radiation treatment within 12 weeks of their surgery date

Who may not be able to join:

  • People who are currently receiving chemotherapy or hormonal therapy
  • People who have had or currently have another cancer whose history or treatment could interfere with how the trial measures safety or effectiveness
  • People who have previously had radiation therapy to the pelvic area
  • People who have an active infection of the urinary or genital tract that requires antibiotics, unless it is a straightforward urinary tract infection
  • People who have a history of active inflammatory bowel disease requiring treatment, such as Crohn's disease or ulcerative colitis
  • People who have a psychiatric or medical condition that the trial investigator considers would make participation in the study unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaled Alektiar, MD, Memorial Sloan Kettering Cancer Center

Phone: 212-639-7981

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 December 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

feasibility of B-mode ultrasound imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov